The U.S. Supreme Court claimed it was merely applying well-established precedents. But that’s not how many experts view the decision in Mayo Collaborative Services v. Prometheus Laboratories.
Quoted in New Laws of Nature Law: Ruling Questions Scientific Patents View Publication Law360
Addressing Breach of Method-of-Use Patents by Generics
The U.S. Court of Appeals for the Federal Circuit on April 16, 2012, in Bayer Schering Pharma AG v. Sandoz Inc., Nos. 2011-1143, -1228 (Yasmin), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of a U.S. Food and Drug...
Addressing Breach of Method-of-Use Patents by Generics View Publication Duane Morris Alert
Federal Circuit Addresses Infringement of Method-of-Use Patents by Generics in Yasmin® Case
The U.S. Court of Appeals for the Federal Circuit on April 16, 2012, in Bayer Schering Pharma AG v. Sandoz, Inc., Nos. 2011-1143, -1228 (YASMIN®), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of an FDA-approved...
Federal Circuit Addresses Infringement of Method-of-Use Patents by Generics in Yasmin® Case View Publication ACI Conference on Paragraph IV Disputes
Speaker “New Standards in Inequitable Conduct Post-Therasense: Ethical Considerations for Paragraph IV Cases,”
IProperty Owners Association Chat Channel webinar on current topics in IP,
Speaker “Successfully Navigating Claim Construction in Life Sciences Litigation,”
IProperty Owners Association Chat Channel webinar on current topics in IP
Successfully Navigating Claim Construction in Life Sciences Litigation
ACI Conference on Paragraph IV Disputes
Speaker, “New Standards and Controversies in Double Patenting Type Obviousness,”
Intellectual Property Owners Association Chat Channel webinar on current topics in IP
Speaker, “Double Patenting: A Newly Vigorous Defense in Patent Litigation,”
ACI Conference on Paragraph IV Disputes